Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning-Reference-Cited by-同舟云学术

Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning

Published:2023-06 Issue: Volume:29 Page:40-57
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Broussau Sophie,Lytvyn Viktoria,Simoneau Mélanie,Guilbault Claire,Leclerc Mélanie,Nazemi-Moghaddam Nazila,Coulombe Nathalie,Elahi Seyyed Mehdy,McComb Scott,Gilbert Rénald

Funder

National Research Council Canada

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Novel vectors and approaches for gene therapy in liver diseases;Maestro;JHEP Rep.,2021

2. Gene and cell-based therapies for Parkinson's disease: where are we?;Buttery;Neurotherapeutics,2020

3. Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases;Tucci;Mol. Ther.,2021

4. Lentiviral vectors for T cell engineering: clinical applications, bioprocessing and future perspectives;Labbe;Viruses,2021

5. Progress and perspectives in the development of lentiviral vector producer cells;Ferreira;Biotechnol. J.,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioprocess Development and Bioreactor Scale-Up for the Production of Recombinant Lentiviral Viral Vectors in HEK293 Suspension Cell Culture;Biochemistry;2024-06-26

2. Generation of stable suspension producer cell lines for serum‐free lentivirus production;Biotechnology Journal;2024-05

3. Improved Manufacturing Methods of Extracellular Vesicles Pseudotyped with the Vesicular Stomatitis Virus Glycoprotein;Molecular Biotechnology;2024-01-05

4. Inducible HEK293 AAV packaging cell lines expressing Rep proteins;Molecular Therapy - Methods & Clinical Development;2023-09

5. CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells;Advances in Medical Sciences;2023-09